Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular matrix remodeling enzymes are a functional group of secreted enzymes—including proteases (such as matrix metalloproteinases, serine proteases, cysteine proteases), and oxidases (such as lysyl oxidase)—that orchestrate the degradation, processing, and crosslinking of extracellular matrix components. These enzymes are essential for tissue development, wound healing, immune cell migration, and organ morphogenesis; however, their dysregulation drives diverse pathological processes such as cancer metastasis, fibrosis, and chronic inflammation. While they are established as important therapeutic targets, drug development faces substantial challenges due to the lack of target specificity and the critical role these enzymes play in normal tissue maintenance[1][4][5][6].
Inhibition of ECM proteolysis (e.g., MMP inhibitors); Modulation of ECM cross-linking (e.g., lysyl oxidase inhibitors)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix remodeling enzyme.